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ABSTRACT
Cohesin, which in somatic vertebrate cells consists
of SMC1, SMC3, RAD21 and either SA1 or SA2, me-
diates higher-order chromatin organization. To de-
termine how cohesin contributes to the establish-
ment of tissue-specific transcriptional programs, we
compared genome-wide cohesin distribution, gene
expression and chromatin architecture in cerebral
cortex and pancreas from adult mice. More than
one third of cohesin binding sites differ between
the two tissues and these show reduced overlap
with CCCTC-binding factor (CTCF) and are enriched
at the regulatory regions of tissue-specific genes.
Cohesin/CTCF sites at active enhancers and promot-
ers contain, at least, cohesin-SA1. Analyses of chro-
matin contacts at the Protocadherin (Pcdh) and Re-
generating islet-derived (Reg) gene clusters, mostly
expressed in brain and pancreas, respectively, re-
vealed remarkable differences that correlate with the
presence of cohesin. We could not detect significant
changes in the chromatin contacts at the Pcdh locus
when comparing brains from wild-type and SA1 null
embryos. In contrast, reduced dosage of SA1 altered
the architecture of the Reg locus and decreased the
expression of Reg genes in the pancreas of SA1 het-
erozygous mice. Given the role of Reg proteins in
inflammation, such reduction may contribute to the
increased incidence of pancreatic cancer observed
in these animals.
INTRODUCTION
Spatio-temporal control of gene expression in higher eu-
karyotes is essential for development and differentiation
(1–3). Increasing evidence from the use of newly de-
veloped Chromosome Conformation Capture (3C)-based
techniques indicates that such control relies on the abil-
ity of a gene to interact with cis-regulatory elements that
can be located up to 1 Mb away (4,5). These interactions
usually occur within megabase-sized topologically associ-
ated domains (TAD)s, which are largely invariant between
cell types (6–9). Two of the architectural elements involved
in chromatin folding and DNA looping are the CCCTC-
binding factor (CTCF) and cohesin (10–13). CTCF is a
protein highly conserved in higher eukaryotes which has a
central DNA-binding domain with 11 zinc fingers and has
been classically considered an insulator (14). Cohesin is a
ring-shaped complex conserved from yeast to human that is
composed of four subunits: SMC1, SMC3, RAD21/SCC1
and SA/STAG/SCC3. Cohesin is well known for mediat-
ing sister chromatid cohesion (15). Its role in transcriptional
regulation, first reported in Drosophila (16), became more
evident when its genome-wide distribution revealed a large
overlap with CTCF both in mouse and human cells (17–19).
Cohesin was then shown to be required for the formation
or stabilization of chromatin loops at certain loci, together
with CTCF or other factors such as the coactivator Medi-
ator (20–27). Although the common and distinct roles of
cohesin and CTCF are still far from being understood, re-
cent results suggest that maintenance of TADs’ boundaries
mostly relies on CTCF whilst both cohesin and CTCF con-
tribute to chromatin contacts within the TADs (28–30).
In somatic vertebrate cells, the SA subunit of cohesin
can be either SA1 or SA2 (31,32). Despite the high degree
of homology between the two proteins, cohesin complexes
carrying one or the other subunit show some functional
specificity. Cohesin-SA1 and cohesin-SA2 mediate telom-
ere and centromere cohesion, respectively, and both con-
tribute to cohesion along chromosome arms (33,34). The
two complexes display a similar genome-wide distribution
in mouse cells. However, in the absence of SA1, a fraction of
cohesin-SA2 repositions to new sites with reduced overlap
with CTCF sites and promoters, and gene expression is al-
tered (35). This result suggests that cohesin-SA1 could have
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a more prominent role in transcriptional regulation than
cohesin-SA2.
Mutations in cohesin and in its loader, NIPBL, cause
a human developmental syndrome known as Cornelia de
Lange. Transcriptional dysregulation of genes sensitive to
cohesin dosage has been proposed to underlie the aetiol-
ogy of the syndrome, at least in part (36–38). Developmen-
tal genes could be particularly sensitive to cohesin (39–41).
Cohesin mutations have also been recently identified in sev-
eral tumour types although it is unclear which dysfunc-
tion of the complex contributes most to the disease, co-
hesion or gene regulation (42–45). Understanding the role
of cohesin in transcriptional control may thus provide im-
portant clues to improve diagnosis and treatment of the
affected patients. Recent studies indicate the existence of
ubiquitous and tissue-specific cohesin positions (23,46–47).
It has been proposed that tissue-specific cohesin binding
sites could help define cell-type-specific transcriptional pro-
grams (48). To explore this possibility, we have analysed
genome-wide cohesin distribution and gene expression in
two different mouse tissues, brain and pancreas, and its con-
tribution to defining active cis-regulatory regions. Changes
in cohesin distribution in a given locus between the two tis-
sues correlate not only with differences in gene expression
but also with distinct chromatin architecture, as judged by
chromosome conformation capture combined with high-
throughput sequencing (4C-seq) analyses. Moreover, mice
deficient in SA1 show altered gene expression in both tis-
sues. Altogether, our results support a prominent contribu-
tion of cohesin to tissue-specific gene expression through
the establishment of the required chromatin contacts. More-
over, we present evidence suggesting that reduced cohesin-
SA1 levels lead to gene expression changes in pancreas that
increase cancer susceptibility in SA1 heterozygous mice.
MATERIALS AND METHODS
Animals
Tissues for the experiments described below were obtained
from adult mice or embryos from a colony of mice heterozy-
gous for SA1 (34). They were housed in a pathogen-free an-
imal facility following the animal care standards of the in-
stitution.
ChIP sequencing (Chip-seq)
Chromatin immunoprecipitation (ChIP) was performed in
tissues (cerebral cortex and pancreas of 8–10-week-old
C57Bl/6 mice, and whole brain of E17.5 embryos) with cus-
tom made rabbit polyclonal antibodies against SA1 and
SMC1 (34), RNApolIISer2P (AB5095, Abcam), CTCF
(07–729, Millipore) and normal rabbit IgG as described (49)
with some modifications. Fresh tissues collected in 6-well
plates containing cold phosphate buffered saline (PBS) with
1-mM PMSF and protease inhibitor cocktail (Roche) were
immediately minced to small fragments of ∼1-mm diame-
ter. Tissue pieces (pooled from three individuals) were cen-
trifuged at 2000 rpm for 2 min at 4oC, resuspended in 1
ml of fixing solution (1% formaldehyde, 50-mM HEPES-
KOH, 100-mM NaCl, 1-mM ethylenediaminetetraacetic
acid (EDTA), 0.5-mM EGTA) and incubated 20 min at
room temperature (RT) in a rotating wheel. Cross-linking
was stopped by adding 1/20 volume of 2.5-M glycine for 5
min at RT. Tissue pieces were washed twice with cold PBS,
recovered by centrifugation at 3000 rpm for 7 min at 4oC, re-
suspended in 2-ml lysis buffer (1% sodium dodecyl sulphate,
10-mM EDTA, 50-mM Tris-HCl pH 8.1; 2 × 107 cells per
ml) and sonicated in Covaris system (shearing time 30 min,
20% duty cycle, intensity 10, 200 cycles per burst and 30
s per cycle). DNA (10 ng of as quantitated by fluorome-
try) was electrophoresed on agarose gel and fractions corre-
sponding to 100–200 bp in length were excised and purified.
ChIP samples were processed into sequencing libraries and
analysed according to Illumina’s ‘ChIP Sequencing Sam-
ple Prep Guide’ (part #11257047 Rev. A), with the excep-
tion that gel extraction was replaced with Agencourt AM-
Pure XP (Beckman Coulter) bead purification. Adapter-
ligated library was completed by limited-cycle polymerase
chain reaction (PCR) with Illumina PE primers (11 cycles).
DNA libraries were applied to an Illumina flow cell for clus-
ter generation and sequenced with the Illumina Genome
Analyzer IIx (GAIIx) or the Illumina HiSeq2000. Image
analysis was performed with Illumina Real Time Analy-
sis software (RTA1.8). Sequence alignment to the reference
genome (NCBIm37/mm9, April 2007) was made with Illu-
mina’s ELANDv2 algorithm on its ‘eland extended’ mode
from within CASAVA-1.7 package, using default settings.
Only reads with unique alignment in the reference genome
were used for the peak detection, which was performed us-
ing MACS v1.4 setting a P-value cut-off of 10−5 and FDR
threshold better than 5% (50). All comparisons were done
with the input track as control and each one of the data sets
as treatment, using RUbioSeq 2.0 as automation analysis
pipeline (51). Genomic interval overlaps and signal distri-
butions were obtained using BEDTools v2.12 (52), Peak-
Analyzer v1.3 (53) and custom UNIX shell scripting. All
the statistical tests and correlations were calculated using R
functions (http://cran.r-project.org).
RNA-sequencing (RNA-seq)
RNA samples (two independent replicates for condition,
with material from four animals in each case) from differ-
ent tissues were extracted using the guanidine thyocianate
buffer, followed by acid phenol chloroform and treated
with DNaseI (Ambion). polyA+RNA was purified with the
Dynabeads mRNA purification kit (Invitrogen), randomly
fragmented and converted to double-stranded cDNA and
processed through subsequent enzymatic treatments of end-
repair, dA-tailing and ligation to adapters as in Illumina’s
‘TruSeq RNA Sample Preparation Guide’ (Part # 15008136
Rev. A). Adapter-ligated library was completed by limited-
cycle PCR with Illumina PE primers (eight cycles). The re-
sulting purified cDNA library was applied to an Illumina
flow cell for cluster generation (TruSeq cluster generation
kit v5) and sequenced on the Genome Analyzer IIx with
SBS TruSeq v5 reagents by following manufacturer’s proto-
cols. Fastq files (54) with 40-nt single-end sequenced reads
were quality-checked with FastQC (S. Andrews, http://
www.bioinformatics.babraham.ac.uk/projects/fastqc/) and
aligned to the mouse genome (GRCm37/mm9) with
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tools 0.1.16 (57) allowing two mismatches and five multi-
hits. Transcript assembly, estimation of their abundances
and differential expression were calculated with Cufflinks
1.3.0 (55) using the mouse genome annotation data set
GRCm37.v65 from Ensembl (58). For differential expres-
sion, genes with FPKM values lower than 0.05 in both
conditions were excluded. GO analyses were performed
using FatiScan tool available at Babelomics suite (http://
www.babelomics.org). To this end, genes were ranked based
on Limma’s moderated t-statistic and GO enrichment was
evaluated by segmentation test. GO terms showing FDR <
0.05 were considered statistically significant.
4C-sequencing (4C-seq)
Preparation of 4C-seq samples was performed as described
(59) with some modifications. Freshly collected tissues were
incubated with collagenase (0.0065% collagenase I in 10%
FBS/PBS for cortex, and 1.33-mg/ml collagenase P in
HBSS for pancreas) for 40 min at 37oC in a shaker. The
resulting cell suspension was filtered through a 40-m cell
strainer in order to get a single cell preparation. Cells were
centrifuged at 1100 rpm for 5 min at RT and the cell pel-
let was resuspended in 10 ml of fixing solution containing
2% formaldehyde in 10% FBS/PBS. After 10 min, 0.125-M
glycine was added to stop fixation and the mixture was incu-
bated for 5 min at RT. Cells were pelleted and nuclei isolated
upon incubation in cold lysis buffer in the following condi-
tions: for the brain, 10 min in 50-mM Tris pH 7.5, 150-mM
NaCl, 5-mM EDTA, 0.5% NP-40, 1% TX-100 + protease
inhibitors cocktail; for the pancreas, 40 min in 50-mM Tris
pH 7.5, 50-mM NaCl, 5-mM EDTA, 1% NP40, 2% TX-
100 + protease inhibitors cocktail. Proper lysis was deter-
mined by methyl green-pyronin staining. HindIII and CvIQ
(in the case of the six-cutter libraries) and DpnII and CvIQ
(in the case of the four-cutter libraries) were used as first and
second cutters, respectively. 4C-seq libraries were amplified
using long primers with 18–21-bp homology to the bait se-
quence and Illumina paired-end adapter flanks. Primer se-
quences were chosen to viewpoint sites, which were as close
as possible to SMC1/SA1 ChIP-seq peaks (Supplementary
Table S7). 4C-seq data analysis and normalization was per-
formed with 4Cseqpipe (60) on the NCBI Build 37 mouse
genome assembly.
Microarray analysis of gene expression in pancreas
Pancreas from wild-type and SA1-heterozygous mice (five
replicates corresponding to five individuals per genotype)
were removed and immediately processed to isolate total
RNA using guanidine thyocianate buffer, followed by acid
phenol chloroform. Since isolation of high-quality RNA
from pancreas is challenging due to the large quantities
of RNases, RNA Integrity Numbers were in the range
6.5–8.4 when assayed by Lab-chip technology on an Ag-
ilent 2100 Bioanalyzer. Hundred nanograms of RNA per
condition were analysed by two-colour hybridization on
Whole Mouse Genome DNA microarrays (G4852A; Agi-
lent) and images were quantified with Agilent Feature Ex-
traction Software (v. 10.7). Differentially expressed genes
between SA1-heterozygous and wild-type MEFs were ob-
tained by Limma (Smyth GK; Bioconductor project; http:
//www.bioconductor.org). FDR adjustment was employed
to account for multiple testing.
Quantitative RT-PCR and protein analysis
Total RNA extracted as described above was treated with
DNaseI (Ambion), and cDNAs were prepared according
to the manufacturer’s instructions using the Superscript II
reverse transcriptase (Invitrogen). qRT-PCR analysis was
performed using the SYBR Green PCR Master Mix and an
ABI Prism R© 7900HT instrument (Applied Biosystems R©).
Primers (Supplementary Table S8) were designed using
OligoPerfect DesignerTM (Invitrogen) and reactions were
performed in triplicate. Quantifications were normalized to
endogenous GAPDH, using the Ct method. To check
cohesin-SA1 levels in pancreas of wild type and SA1 het-
erozygous mice, extracts were prepared from a piece of tis-
sue that was pulverized in a mortar containing liquid ni-
trogen and lysed in RIPA buffer. Equal amounts of protein
were run in 7.5 Bis/Tris gels followed by western blotting
with antibodies against SA1 and Rad21 (34) and GAPDH
(Sigma, G8795).
Chromatin states
Chromatin segmentation was performed with
ChromHMM (61) including 15 states in the model
and setting a bin size of 500 bp for the model learning and
segmentation. The model learning was done using adult
brain SMC1 and SA1 marks obtained in this study, and
marks from LICR-m (9): 8-weeks cerebellum (H3K27Me3)
and adult cortex (CTCF, H3K4Me1, H3K4Me3 and
H3K27Ac).
Data access
ChIP-seq, RNA-seq and 4C-seq from this study have been
submitted to GEO database (GSE59119).
RESULTS
Cohesin distribution is tissue-specific
With the aim to understand the functional role of co-
hesin in the establishment of tissue-specific transcriptional
programs we performed ChIP followed by massive paral-
lel DNA sequencing (ChIP-seq) analysis with antibodies
against two cohesin subunits, SMC1 and SA1, in two tis-
sues derived from different mouse embryonic germ layers.
We chose cerebral cortex as representative of ectoderm lin-
eage and pancreas as part of the digestive apparatus, derived
from the endoderm embryonic layer. Genome-wide analy-
sis of the sequenced tags defined 46 398 and 35 048 bind-
ing sites for SMC1 and SA1, respectively, in cortex and 32
381 and 26 896 SMC1 and SA1 binding sites, respectively,
in pancreas (cut-off P-value of 10−5 and FDR of 0.05; Fig-
ure 1A and Supplementary Table S1). As expected, most
SA1 sites are also SMC1 sites. The sites with SMC1 but no
SA1 could correspond to cohesin-SA2.
We next compared cohesin distribution in the two tis-
sues and found that 20 003 SMC1 binding sites are com-
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Figure 1. A large fraction of genomic cohesin positions are tissue-specific. (A) Number of cohesin SMC1 and SA1 positions in cerebral cortex and pancreas
from 10 week-old mice obtained by ChIP-seq. Two replicates corresponding to independent experiments containing tissue from at least three individuals
were performed. (B) Venn diagrams showing the overlap between SMC1 and SA1 positions in each tissue and between tissues. For cohesin and CTCF
peaks (see Supplementary Figure S1), overlap is defined as reciprocal coincidence over at least 50% of peak length. (C) UCSC genome browser images
illustrating cortex-specific (upper panel) and pancreas-specific (lower panel) cohesin positions located in chromosomes 11 and 15, respectively. The values
for ChIP-seq data (y-axis) are normalized to input.
thus leaving an important number of tissue-specific cohesin
positions (26 395 in cortex and 12 378 in pancreas; Fig-
ure 1B and C). If we consider cohesin positions as the sum
of SMC1 and SA1 positions, the overlap increases slightly
to 48% of cortex and 63% of pancreas (Supplementary Fig-
ure S1A). Ubiquitous and tissue-specific cohesin positions
are similarly distributed amongst gene-associated and in-
tergenic regions (Supplementary Figure S1A). Consistent
with previous reports of a large overlap between cohesin
and CTCF, 64% of cohesin binding sites that we identi-
fied in cortex coincide with CTCF sites reported in the
same tissue (9). These cohesin/CTCF positions represent
86% of ubiquitous cohesin sites but only 41% of cortex-
specific sites (Supplementary Figure S1B). The fraction of
cohesin/CTCF sites is reduced to 39% in pancreas due to
the smaller number of CTCF sites identified in this tissue
(17 625) compared to cohesin sites (38 002), but they rep-
resent 56% of ubiquitous cohesin sites and only 10% of
pancreas-specific sites (Supplementary Figure S1C). Thus,
cohesin/CTCF sites are more invariant between tissues
than cohesin/non-CTCF sites.
We observed that cohesin distributes throughout the
body of highly expressed genes encoding pancreatic en-
zymes, such as chemotrypsinogen or amylase, same as
the elongating form of RNA polymerase II (RNA pol II;
Supplementary Figure S2A). Cohesin can also be found
throughout the body of some of the genes most highly ex-
pressed in cortex, although its accumulation is not as high
as in the pancreatic genes described above (Supplementary
Figure S2B and C). Cohesin could be promoting efficient
transcription by RNA pol lI in these genes, as recently de-
scribed in Drosophila (62).
Cohesin distribution correlates with tissue-specific transcrip-
tion
We next analysed cohesin distribution around the transcrip-
tion start site (TSS) of the genes that are expressed specif-
ically in each tissue. To assess tissue-specific gene expres-
sion RNA-seq was performed in the same samples used for
ChIP (Supplementary Tables S2 and S3). We defined tissue-
specific genes as those differentially expressed when com-
pared with the other tissue (log2FC > 4, FDR < 0.05), in
which the expression should be low, i.e. Fragments Per Kilo-
base of exon per Million fragments mapped (FPKM) <3.
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and 514 pancreas-specific genes. Gene ontology analyses
verified the functional specificity of the gene sets (Figure 2A
and Supplementary Table S4). We found that cohesin bind-
ing sites (both SMC1 and SA1) are enriched around the TSS
of tissue-specific genes mainly in the tissue in which they are
expressed (Figure 2B).
In order to demonstrate a causal relationship between
the presence of cohesin at promoters and gene expression
in vivo, we used SA1 deficient mice that we previously gen-
erated. Homozygous deletion of the gene encoding SA1
is embryonic lethal but a low percentage of embryos sur-
vive to late developmental stages (35). We therefore per-
formed ChIP-seq and RNA-seq analysis in brains obtained
from E17.5 wild-type and SA1 null embryos (Supplemen-
tary Figure S3 and Supplementary Tables S2 and S3). Con-
sistent with our previous results in mouse embryo fibrob-
lasts, lack of cohesin-SA1 had a profound effect on gene ex-
pression also in the brain, featured by changes in hundreds
of genes (Figure 2C and Supplementary Table S4). Genes
down-regulated in the SA1 null brains have cohesin around
their TSSs in wild-type tissue but little is left in the mutant
(Figure 2D and Supplementary Table S5). In contrast, genes
up-regulated in the SA1 null brains show no cohesin enrich-
ment around their promoters. In this case, the spatial orga-
nization of the loci containing the affected genes may be al-
tered without involving discrete promoter–enhancer DNA
looping.
Cohesin contributes to defining the functionality of the chro-
matin landscape
To further explore the relationship between cohesin and
functional genomic elements, we performed chromatin
profiling combining our own data for cohesin SMC1
and SA1 in cortex with available data from chromatin
marks associated with enhancers (H3K4me1), promoters
(H3K4me3), active elements (H3K27Ac), repressed regions
(H3K27me3) and CTCF in the same tissue ((9); Supple-
mentary Figure S4). Thirteen chromatin states obtained
from the analysis were given a candidate annotation––as
in (63)––and their functional enrichment in tissue-specific
promoters and enhancers was assessed (Figure 3A). Active
promoters can have no cohesin (AP), cohesin but no CTCF
(APC) or both cohesin and CTCF (APCC). Cohesin-SA1 is
likely to be present at most promoters featured by the APCC
state, since the probability of having SA1 is similar to SMC1
(83% and 94%, respectively). In the APC state, the differ-
ence is more prominent (55% SA1 and 86% SMC1), sug-
gesting that cohesin at some of these promoters could be
cohesin-SA2. The promoters of the genes more transcribed
in cortex (FPKM > 6) are more often defined by the APC
state than by the APCC state (Figure 3B). Moreover, the
difference in enrichment in cortex-specific promoters com-
pared to pancreas-specific promoters is also higher for the
APC state than for the APCC (Figure 3A, right). These re-
sults further support the involvement of cohesin in tissue-
specific transcription.
Inactive promoters or repressed regions (defined by the
presence of H3K27Me3, chromatin state labelled in grey in
Figure 3A) do not contain cohesin or CTCF. Cohesin and
CTCF are also absent from strong enhancers (chromatin
state labelled in dark green in Figure 3A), whereas they co-
occur at a fraction of poised/weak enhancers (labelled in
light green in Figure 3A). This suggests that the activity of
weak enhancers could rely on the ability of cohesin/CTCF
to stabilize genomic interactions with their target gene pro-
moters whereas this function could be dispensable in the
case of strong enhancers. As in the case of APCC, most
of these cohesin/CTCF sites have, at least, cohesin-SA1.
Finally, there are four chromatin states that have CTCF
and/or cohesin in the absence of any of the other chromatin
marks. Consistent with the overlap between cohesin and
CTCF, the CTCF-only state occupies 0.4% of the genome
whilst the two CTCF/cohesin states, which differ in the
probability of having SA1, together encompass 1.2% of
the genome. The functional distinction between these three
states is unclear at the moment. A state with CTCF and no
chromatin marks has been previously annotated as ‘Insula-
tor’ (63). The cohesin-only state is the most enriched at gene
promoters, in particular those expressed specifically in cor-
tex (Figure 3A and Supplementary Figure S5). Thus, the
presence of cohesin at a promoter is a strong indicator of
its activity and may predict gene expression in cases where
classical active promoter-associated chromatin marks (e.g.
H3K27Ac) are not detected.
We next assessed the overlap between cortex-specific po-
sitions for cohesin and CTCF with the chromatin marks of
this tissue. For this, we defined cortex-specific CTCF sites
as those present in cortex but not in pancreas (Supplemen-
tary Figure S6). Cortex-specific cohesin binding sites dis-
play a better overlap with enhancer and promoter marks
(H3K4Me1 and H3K4Me3) than ubiquitous cohesin bind-
ing sites (Figure 3C, purple rectangle). This is not the case
when comparing the overlap of cortex-specific and com-
mon CTCF positions with those same chromatin marks
(Figure 3C, blue rectangle). Moreover, cortex-specific co-
hesin is more frequently found at the promoters of cortex-
specific genes than cortex-specific CTCF (Figure 3C, com-
pare green and yellow rectangles). These observations in-
dicate that cohesin could have a more prominent role in
controlling tissue-specific transcription whilst CTCF would
be more involved in the transcription of non tissue-specific
genes.
Tissue-specific transcription correlates with tissue-specific
architecture
Cohesin has been proposed to stabilize cis-interactions be-
tween distal genomic elements involved in gene regula-
tion. To ascertain the correlation between tissue-specific
transcription and chromatin architecture mediated by co-
hesin, we performed 4C-seq analyses in the Protocadherin
(Pcdh) clusters, a genomic region containing genes ex-
pressed specifically in the brain (Figure 4 and Supplemen-
tary Table S6). Pcdh alpha, beta and gamma clusters en-
code more than 50 protein isoforms as a result of stochastic
promoter choice and alternative splicing (64). Mouse mod-
els deficient for CTCF, for the cohesin loader Nipbl or for
cohesin-SA1, present altered expression of the Pcdh genes
(35,65–67). Moreover, 3C analyses in mouse and human
neuroblastoma cell lines indicate that cohesin and CTCF
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Figure 2. Cohesin is enriched at the promoters of actively transcribed genes. (A) Transcriptional profiles from the cortex (left) and pancreas (right) of
10-week-old mice were determined by RNA-seq. Tissue-specific genes were selected for each tissue (see main text for details) and further confirmed by
Gene Ontology analysis. (B) Cohesin distribution around the TSS (±6 kb) of genes expressed specifically in cortex (upper panels) and pancreas (lower
panels) defined as peak frequency (%). Both SMC1 and SA1 distributions are shown. (C) Gene expression changes between wild-type and SA1 null brains
(KO) from E17.5 embryos were characterized by RNA-seq (FDR < 0.05). (D) Cohesin distribution around the TSS of genes found to be down-regulated
(left) and up-regulated (right) in SA1 null embryonic brains.
the Pcdh alpha cluster and individual upstream promoters
(26,27). We first chose one of these enhancers, HS5–1, as
anchoring point to identify long-range interactions both in
cortex and pancreas (Figure 4B, top). In cortex, the Pcdh al-
pha locus is folded in such a way that the HS5–1 enhancer
is spatially close to most Pcdh alpha gene promoters. Inter-
acting regions correlate with both cohesin distribution and
Pcdh alpha gene expression (see RNA-seq track at the bot-
tom of Figure 4B). Importantly, such spatial conformation
is tissue specific, since none of the described interactions can
be detected in pancreas.
There is another enhancer located downstream of the
Pcdh gamma cluster, HS16–20 (68). 4C-seq analysis using
as viewpoint a strong cohesin binding site present in this
enhancer revealed long-range interactions with several ge-
nomic regions located within the Pcdh beta locus and even
in the Pcdh alpha locus (green and blue arrowheads in Fig-
ure 4, middle, respectively). These results can explain why
deletion of the HS16–20 region in mice leads to a nearly
complete loss of expression across the Pcdh beta cluster,
whilst a much less drastic effect is observed for the genes of
the immediately adjacent Pcdh gamma cluster (68). These
interactions could not be detected in pancreas.
We next repeated the 4C-seq analysis using brains from
wild-type and SA1 null embryos. The chromatin contacts
between HS5–1 enhancer and the Pcdh alpha promoters
were analogous to those described in adult brain, consis-
tent with the presence of similar cohesin-SA1 peaks. Unex-
pectedly, most contacts were also maintained in SA1 null
brains (Supplementary Figure S7). Quantitation of SMC1
binding to Pcdha4 and Pcdha6 promoters revealed only a
2-fold reduction in the absence of SA1, suggesting that this
remaining cohesin could be sufficient to support the ob-
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Figure 3. Cohesin is present at active promoters and enhacers. (A) Chromatin profiling in adult cortex by means of Hidden Markov Model (HMM) led
to define 13 chromatin states (shown in different colours) according to the observed frequency of different chromatin marks (H3K4Me1, H3K4Me3,
H3K27Me3, H3K27Ac), CTCF and cohesin SMC1 and SA1. The numbers in the table on the left correspond to the frequency with which a given mark is
found at genomic positions corresponding to the chromatin state, annotated on the middle and assigned a colour code. Green shading indicates intensity
(0–100). Genome% indicates the percentage of the genome corresponding to each chromatin state. The columns on the right show the functional enrichment
of each chromatin state in cortex and pancreas-specific promoters (as selected in Figure 2) and cortex and small-intestine enhancers (as defined in (9)).
(*) The sate named ‘CTCF&CohesinSA1’ contains, at least, cohesin-SA1 but it may also contain cohesin-SA2. (B) Genes were classified into quartiles
according to their expression levels, obtained by RNA-seq, as follows: Q1, FPKM = 0 (n = 18 361), no expression; Q2, 0<FPKM≤0.296312 (n = 7316),
low expression; Q3, 0.296312<FPKM≤6.032485 (n = 9315), moderate expression; Q4, FPKM>6.032485 (n = 9316), high expression. The frequency of
the indicated chromatin states is shown for the quartiles containing expressed genes (Q1–Q3). AP, active promoters; APC, active promoters with cohesin;
APCC, active promoters with cohesin and CTCF; PR, Polycomb repressed. (C) Heat-map visualization of the pairwise overlap between cerebral cortex
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Figure 4. Chromatin architecture of the Pcdh locus in adult cortex and pancreas. (A) Details of the chromosome 18qB3 region containing the mouse Pcdh
alpha, beta and gamma clusters. HS5–1 and HS16–20 enhancer regions are shown. (B) Upper panel: chromatin interactions detected by 4C-seq in cerebral
cortex and pancreas using a 20-kb window size in the main trend subpanel. Red arrowheads indicate viewpoint positions. Middle and bottom panels show
cohesin positions (defined by ChIP-seq) and gene expression (obtained by RNA-seq), respectively.
tom). The contacts between the HS16–20 enhancer and the
Pcdh beta cluster were decreased in the wild-type embryonic
brain compared with the adult and even further reduced
in the SA1 null brain. This was accompanied by decreased
SA1 peak height at some positions that could be more rele-
vant for the chromatin contact (blue arrowhead in Supple-
mentary Figure S7, right). Both binding of SMC1 and tran-
scription of genes in this region were reduced in brains of
SA1 null embryos compared to wild-type (Pcdhb17, 20 and
21; Figure 7B and C in (35)). Thus, in this particular locus,
a better correlation exists between cohesin-SA1 levels, chro-
matin organization and gene expression.
Cohesin-SA1 contribution to chromatin architecture in the
Reg locus
We recently reported increased incidence of pancreatic tu-
mours in SA1 heterozygous mice (34). As judged by im-
munoblot analysis, SA1 protein levels are reduced in the
pancreas of SA1 heterozygous animals compared to wild-
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Figure 5. Chromatin architecture of the Reg locus in adult cortex and pancreas. (A) Levels of cohesin were assayed by immunoblot with SA1 and Rad21
antibodies in pancreas from wild-type and SA1 heterozygous mice (two individuals per genotype). GAPDH serves as loading control. (B) Table showing
the four genes differentially expressed (FDR < 0.15) in pancreas from 10-week-old wild-type and SA1 heterozygous mice. (C) Validation of transcriptional
changes in Reg genes by RT-qPCR. At least three individuals per condition were analysed. A two-tailed Student’s t-test was applied. Data are shown as
mean ± SEM (standard error of the mean). (D) The amount of cohesin SA1 and SMC1 at the sites in the Reg locus marked in (E) was analysed by ChIP-
qPCR in the pancreas of wild-type and SA1 heterozygous mice. At least four animals per condition were used for the analysis. (E) Cohesin distribution
across the Reg locus in cortex and pancreas, as determined by ChIP-seq. CTCF binding sites are also indicated. Black lines specify the position of primer
pairs (1, 2 and 3) used in (D). The lower panel shows the analysis of the three-dimensional organization of the Reg locus in pancreas from wild-type and
SA1 heterozygous mice by 4C-seq. Main trend corresponds to a 5-kb window size. The position of the viewpoint (VP2) is indicated (green arrow).
creas obtained from healthy 10-week-old wild-type and SA1
heterozygous mice detected significant changes in the ex-
pression of only four genes (FDR < 0.15; Figure 5B and
C). Three of them, Reg2, Reg3a and Reg3b (from Regen-
erating islet-derived), belong to a gene family strongly as-
sociated with pancreatitis (69–71). Interestingly, Reg genes
are organized in a cluster, consistent with the idea that co-
hesin may be important to coordinate the expression of spa-
tially related genes (72). They are highly expressed in pan-
creas and not in cortex. In pancreas, cohesin bound abun-
dantly within the Reg gene cluster but was absent from the
surrounding regions. The opposite was observed in cortex
(Supplementary Figure S8A). In agreement with reported
Hi-C data (7), analysis of chromatin contacts by 4C-seq
using a viewpoint located in Reg1 (VP1 in Supplemen-
tary Figure S8A) revealed that this region is more densely
packed in adult cortex than in pancreas. Some differential
interactions could be detected more than 1 Mb away from
the viewpoint in the two tissues. This architecture suggests
that the presence of cohesin at the Reg locus in pancreas
might prevent chromatin compaction and positively regu-
late gene expression. Consistent with this possibility, the
amount of cohesin bound to three sites inside the Reg lo-
cus was clearly reduced in the pancreas of SA1 heterozy-
gous animals compared to wild-type (Figure 5D). More-
over, a high-resolution 4C analysis performed in pancreas
from wild-type and SA1 heterozygous mice using two ad-
ditional viewpoints within the Reg locus showed different
interaction patterns (VP2 in Figure 5E and VP3 in Supple-
mentary Figure S8B). An increased number of chromatin
contacts were observed in SA1 deficient pancreas, reminis-
cent of the higher compaction observed in cortex. The Reg
locus could therefore be particularly sensitive to a decrease
in cohesin levels. It is tempting to speculate that altered gene
expression of Reg genes contributes to tumourigenesis in
SA1 deficient mice.
DISCUSSION
Previous efforts to identify tissue-specific cohesin signatures
have compared cohesin binding sites with those of ubiqui-
tous and tissue-specific transcriptional regulators in a single
tissue (47) or have examined cohesin distribution in human
cancer cell lines (46). We here report the first comparison
of cohesin distribution in vivo in two different tissues from
the same individuals and its correlation with gene expres-
sion and chromatin architecture at selected loci. Consistent
with previous results, we found that a significant propor-
tion of cohesin positions are only identified in the tissue un-
der analysis. Such tissue-specific binding sites are present
not only at gene promoters but appear to mark other func-
tional cis-regulatory elements. In the mouse and human
genomes, cohesin positions largely overlap with those of
CTCF (17–19,23,35). We combined chromatin marks re-
cently characterized in an 8-week-mouse-old brain (9) with
our data on cohesin distribution to get a comprehensive
idea of cohesin contribution to define the genomic land-
scape in cerebral cortex. Contrary to the conclusion of (47)
that cohesin/CTCF sites show minimal signs of transcrip-
tional activity and that CTCF is absent from most genomic
elements featured by enhancer marks, we find cohesin and
CTCF together at active promoters and enhancers. How-
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to genes less transcribed than those containing cohesin and
that CTCF/no cohesin sites do not co-occur with active
promoter marks. Our analysis further reveals that cohesin
complexes that co-occur with CTCF at active promoters
and enhancers most likely contain the SA1 subunit. Consis-
tent with previous reports, we also observe that cohesin has
a more prominent role in controlling tissue-specific tran-
scription, whilst CTCF is more relevant for the expression
of common/housekeeping genes (9,47).
Cohesin contributes to transcriptional regulation in sev-
eral ways. One is by facilitating long-range interactions.
Our analysis of chromatin contacts at the Pcdh clusters in
adult pancreas, adult cortex and embryonic brain by means
of 4C-seq reveals remarkable differences between the two
adult tissues and, to a lesser extent, between two develop-
mental stages of the same tissue. These architectural dif-
ferences are accompanied by changes both in gene expres-
sion and cohesin distribution. Assessing the role of cohesin
in the establishment and/or maintenance of the observed
chromatin contacts is not trivial, since cohesin is essential
for proliferation. Nevertheless, conditional gene ablation or
forced cleavage of cohesin in cells leading to notable––but
incomplete––removal of the complex from chromatin re-
sults in changes in chromatin architecture and gene expres-
sion (13,29–30). Although we could detect some changes in
chromatin contacts in the Pcdh clusters of embryonic brains
upon complete ablation of cohesin-SA1, they were less
dramatic than expected. We had previously reported that
cohesin-SA1 is more prevalent in this locus than cohesin-
SA2 and that cohesin occupancy is clearly reduced in SA1
null brains (35). Here we show that the reduction in bound
cohesin may not be so dramatic at other Pcdha promoters
and therefore the remaining cohesin, necessarily cohesin-
SA2, could be sufficient to maintain locus architecture in
the absence of cohesin-SA1. Finally, whilst in the afore-
mentioned studies the effect of removing cohesin is assessed
within hours of the elimination, the SA1 null embryos de-
velop from the zygote in the absence of cohesin-SA1 and
those that survive to 17.5 dpc may have found ways to cope
with this loss.
In contrast to the Pcdh locus, the Reg locus appears to
be sensitive to a decrease in cohesin levels. A different set
of chromatin contacts can be observed in the Reg locus in
pancreas from wild-type and SA1 heterozygous mice. We
favor the hypothesis that cohesin is one of the several ele-
ments promoting a particular chromatin contact, including
CTCF, transcription factors or nearby transcriptional ac-
tivity. The combination of such contributions would dictate
the probability of the contact and therefore, the dependency
on cohesin would be variable amongst different genomic
loci. A 2-fold reduction in the amount of SA1 protein in
pancreas leads to a clear decrease in cohesin binding in the
Reg locus. We propose that this reduction, in turn, alters
chromatin architecture to make it more similar to the archi-
tecture of the Reg locus in cortex, where the expression of
Reg genes is around three orders of magnitude lower than
in pancreas.
Impaired homeostasis of the pancreas due to altered ex-
pression of the Reg genes could make SA1 heterozygous
mice prone to pancreatic cancer (34). Four out of five hu-
man Reg genes are present in a single locus at chromosome
2 (2p12) that is syntenic to the murine locus described in
this study (6qC3). Cohesin positions can be found within
the human locus in a cell line of pancreatic origin but not
in glioblastoma cells (our own unpublished data). Thus, the
chromatin architecture that we have described for the Reg
gene cluster in mice could be conserved in humans and af-
fect Reg gene expression. Interestingly, 20% of pancreatic
cancer cases analysed by the ICGC (90/450) harbour mu-
tations in the SA1 gene. Even though the actual impact of
most of these mutations in SA1 expression and/or function
is unclear, their incidence seems to be particularly high in
this type of tumour. Our current results suggest that altered
chromatin architecture leading to transcriptional dysregu-
lation may be one of the mechanisms underlying the role of
cohesin mutations in human cancer (45,73)
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We wish to thank G. Gómez-López of the Bioinformatics
Unit for the peak calling analysis of CTCF in pancreas, O.
Domı́nguez and his team in the Genomics Unit for help
with ChIP-seq and M. Serrano for his continuous support.
FUNDING
The Spanish Ministry of Economy and Competitiveness
(MINECO) [BFU2013-48481-R to A.L.]; ‘Ramón y Cajal’
Contract [RYC-2010-06122 to A.C.]; Fundación La Caixa
[PhD Fellowship to S.R.]. Funding for open access charge:
The Spanish Ministry of Economy and Competitiveness
(MINECO) [BFU2013-48481-R].
Conflict of interest statement. None declared.
REFERENCES
1. Fraser,P. and Bickmore,W. (2007) Nuclear organization of the
genome and the potential for gene regulation. Nature, 447, 413–417.
2. Spitz,F. and Furlong,E.E. (2012) Transcription factors: from
enhancer binding to developmental control. Nat. Rev. Genet., 13,
613–626.
3. Cavalli,G. and Misteli,T. (2013) Functional implications of genome
topology. Nat. Struct. Mol. Biol., 20, 290–299.
4. Li,G., Ruan,X., Auerbach,R.K., Sandhu,K.S., Zheng,M., Wang,P.,
Poh,H.M., Goh,Y., Lim,J., Zhang,J. et al. (2012) Extensive
promoter-centered chromatin interactions provide a topological basis
for transcription regulation. Cell, 148, 84–98.
5. Sanyal,A., Lajoie,B.R., Jain,G. and Dekker,J. (2012) The long-range
interaction landscape of gene promoters. Nature, 489, 109–113.
6. Lieberman-Aiden,E., van Berkum,N.L., Williams,L., Imakaev,M.,
Ragoczy,T., Telling,A., Amit,I., Lajoie,B.R., Sabo,P.J.,
Dorschner,M.O. et al. (2009) Comprehensive mapping of long-range
interactions reveals folding principles of the human genome. Science,
326, 289–293.
7. Dixon,J.R., Selvaraj,S., Yue,F., Kim,A., Li,Y., Shen,Y., Hu,M.,
Liu,J.S. and Ren,B. (2012) Topological domains in mammalian
genomes identified by analysis of chromatin interactions. Nature, 485,
376–380.
8. Nora,E.P., Lajoie,B.R., Schulz,E.G., Giorgetti,L., Okamoto,I.,
Servant,N., Piolot,T., van Berkum,N.L., Meisig,J., Sedat,J. et al.
(2012) Spatial partitioning of the regulatory landscape of the










enter user on 30 M
arch 2020
3066 Nucleic Acids Research, 2015, Vol. 43, No. 6
9. Shen,Y., Yue,F., McCleary,D.F., Ye,Z., Edsall,L., Kuan,S.,
Wagner,U., Dixon,J., Lee,L., Lobanenkov,V.V. et al. (2012) A map of
the cis-regulatory sequences in the mouse genome. Nature, 488,
116–120.
10. Gibcus,J.H. and Dekker,J. (2013) The hierarchy of the 3D genome.
Mol. Cell, 49, 773–782.
11. Handoko,L., Xu,H., Li,G., Ngan,C.Y., Chew,E., Schnapp,M.,
Lee,C.W., Ye,C., Ping,J.L., Mulawadi,F. et al. (2011) CTCF-mediated
functional chromatin interactome in pluripotent cells. Nat. Genet.,
43, 630–638.
12. DeMare,L.E., Leng,J., Cotney,J., Reilly,S.K., Yin,J., Sarro,R. and
Noonan,J.P. (2013) The genomic landscape of cohesin-associated
chromatin interactions. Genome Res., 23, 1224–1234.
13. Phillips-Cremins,J.E., Sauria,M.E., Sanyal,A., Gerasimova,T.I.,
Lajoie,B.R., Bell,J.S., Ong,C.T., Hookway,T.A., Guo,C., Sun,Y. et al.
(2013) Architectural protein subclasses shape 3D organization of
genomes during lineage commitment. Cell, 153, 1281–1295.
14. Ong,C.T. and Corces,V.G. (2014) CTCF: an architectural protein
bridging genome topology and function. Nat. Rev. Genet., 15,
234–246.
15. Nasmyth,K. and Haering,C.H. (2009) Cohesin: its roles and
mechanisms. Annu. Rev. Genet., 43, 525–558.
16. Dorsett,D., Eissenberg,J.C., Misulovin,Z., Martens,A., Redding,B.
and McKim,K. (2005) Effects of sister chromatid cohesion proteins
on cut gene expression during wing development in Drosophila.
Development, 132, 4743–4753.
17. Rubio,E.D., Reiss,D.J., Welcsh,P.L., Disteche,C.M., Filippova,G.N.,
Baliga,N.S., Aebersold,R., Ranish,J.A. and Krumm,A. (2008) CTCF
physically links cohesin to chromatin. Proc. Natl. Acad. Sci. U.S.A.,
105, 8309–8314.
18. Wendt,K.S., Yoshida,K., Itoh,T., Bando,M., Koch,B.,
Schirghuber,E., Tsutsumi,S., Nagae,G., Ishihara,K., Mishiro,T. et al.
(2008) Cohesin mediates transcriptional insulation by
CCCTC-binding factor. Nature, 451, 796–801.
19. Parelho,V., Hadjur,S., Spivakov,M., Leleu,M., Sauer,S.,
Gregson,H.C., Jarmuz,A., Canzonetta,C., Webster,Z., Nesterova,T.
et al. (2008) Cohesins functionally associate with CTCF on
mammalian chromosome arms. Cell, 132, 422–433.
20. Hadjur,S., Williams,L.M., Ryan,N.K., Cobb,B.S., Sexton,T.,
Fraser,P., Fisher,A.G. and Merkenschlager,M. (2009) Cohesins form
chromosomal cis-interactions at the developmentally regulated IFNG
locus. Nature, 460, 410–413.
21. Nativio,R., Wendt,K.S., Ito,Y., Huddleston,J.E., Uribe-Lewis,S.,
Woodfine,K., Krueger,C., Reik,W., Peters,J.M. and Murrell,A. (2009)
Cohesin is required for higher-order chromatin conformation at the
imprinted IGF2-H19 locus. PLoS Genet., 5, e1000739.
22. Mishiro,T., Ishihara,K., Hino,S., Tsutsumi,S., Aburatani,H.,
Shirahige,K., Kinoshita,Y. and Nakao,M. (2009) Architectural roles
of multiple chromatin insulators at the human apolipoprotein gene
cluster. EMBO J., 28, 1234–1245.
23. Kagey,M.H., Newman,J.J., Bilodeau,S., Zhan,Y., Orlando,D.A., van
Berkum,N.L., Ebmeier,C.C., Goossens,J., Rahl,P.B., Levine,S.S. et al.
(2010) Mediator and cohesin connect gene expression and chromatin
architecture. Nature, 467, 430–435.
24. Degner,S.C., Verma-Gaur,J., Wong,T.P., Bossen,C., Iverson,G.M.,
Torkamani,A., Vettermann,C., Lin,Y.C., Ju,Z., Schulz,D. et al. (2011)
CCCTC-binding factor (CTCF) and cohesin influence the genomic
architecture of the Igh locus and antisense transcription in pro-B
cells. Proc. Natl. Acad. Sci. U.S.A., 108, 9566–9571.
25. Hou,C., Dale,R. and Dean,A. (2010) Cell type specificity of
chromatin organization mediated by CTCF and cohesin. Proc. Natl.
Acad. Sci. U.S.A., 107, 3651–3656.
26. Guo,Y., Monahan,K., Wu,H., Gertz,J., Varley,K.E., Li,W.,
Myers,R.M., Maniatis,T. and Wu,Q. (2012) CTCF/cohesin-mediated
DNA looping is required for protocadherin alpha promoter choice.
Proc. Natl. Acad. Sci. U.S.A., 109, 21081–21086.
27. Monahan,K., Rudnick,N.D., Kehayova,P.D., Pauli,F.,
Newberry,K.M., Myers,R.M. and Maniatis,T. (2012) Role of
CCCTC binding factor (CTCF) and cohesin in the generation of
single-cell diversity of Protocadherin-alpha gene expression. Proc.
Natl. Acad. Sci. U.S.A., 109, 9125–9130.
28. Seitan,V.C., Faure,A.J., Zhan,Y., McCord,R.P., Lajoie,B.R.,
Ing-Simmons,E., Lenhard,B., Giorgetti,L., Heard,E., Fisher,A.G.
et al. (2013) Cohesin-based chromatin interactions enable regulated
gene expression within preexisting architectural compartments.
Genome Res., 23, 2066–2077.
29. Sofueva,S., Yaffe,E., Chan,W.C., Georgopoulou,D., Vietri Rudan,M.,
Mira-Bontenbal,H., Pollard,S.M., Schroth,G.P., Tanay,A. and
Hadjur,S. (2013) Cohesin-mediated interactions organize
chromosomal domain architecture. EMBO J., 32, 3119–3129.
30. Zuin,J., Dixon,J.R., van der Reijden,M.I., Ye,Z., Kolovos,P.,
Brouwer,R.W., van de Corput,M.P., van de Werken,H.J.,
Knoch,T.A., van Ijcken,W.F. et al. (2014) Cohesin and CTCF
differentially affect chromatin architecture and gene expression in
human cells. Proc. Natl. Acad. Sci. U.S.A., 111, 996–1001.
31. Losada,A., Yokochi,T., Kobayashi,R. and Hirano,T. (2000)
Identification and characterization of SA/Scc3p subunits in the
Xenopus and human cohesin complexes. J. Cell Biol., 150, 405–416.
32. Sumara,I., Vorlaufer,E., Gieffers,C., Peters,B.H. and Peters,J.M.
(2000) Characterization of vertebrate cohesin complexes and their
regulation in prophase. J. Cell Biol., 151, 749–762.
33. Canudas,S. and Smith,S. (2009) Differential regulation of telomere
and centromere cohesion by the Scc3 homologues SA1 and SA2,
respectively, in human cells. J. Cell Biol., 187, 165–173.
34. Remeseiro,S., Cuadrado,A., Carretero,M., Martı́nez,P.,
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